|
1
|
Allen TC and Moran C: Synchronous
pulmonary carcinoma and pleural diffuse malignant mesothelioma.
Arch Pathol Lab Med. 130:721–724. 2006.PubMed/NCBI
|
|
2
|
Perrot M, Wu L, Wu M and Cho BCJ:
Radiotherapy for the treatment of malignant pleural mesothelioma.
Lancet Oncol. 18:e532–e542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Whitewell F and Rawcliffe RA: Diffuse
malignant pleural mesothelioma and asbestos exposure. Thorax.
26:6–22. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Doll R: Mortality from lung cancer in
asbestos workers. Brit J Indust Med. 12:81–86. 1955.
|
|
5
|
Krug LM, Pass HI, Rusch VW, Kindler HL,
Sugarbaker DJ, Rosenzweig KE, Flores R, Friedberg JS, Pisters K,
Monberg M, et al: Multicenter phase II trial of neoadjuvant
pemetrexed plus cisplatin followed by extrapleural pneumonectomy
and radiation for malignant pleural mesothelioma. J Clin Oncol.
27:3007–3013. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Treasure T, Lang-Lazdunski L, Waller D,
Bliss JM, Tan C, Entwisle J, Snee M, O'Brien M, Thomas G, Senan S,
et al: Extra-pleural pneumonectomy versus no extra-pleural
pneumonectomy for patients with malignant pleural mesothelioma:
clinical outcomes of the Mesothelioma and Radical Surgery (MARS)
randomized feasibility study. Lancet Oncol. 12:763–772. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Flores RM, Pass HI, Seshan VE, Dycoco J,
Zakowski M, Carbone M, Bains MS and Rusch VW: Extrapleural
pneumonectomy versus pleurectomy/decortications in the surgical
management of malignant pleural mesothelioma: Results in 663
patients. J Thoracic Cardiovasc Surg. 135:620–626. 2008. View Article : Google Scholar
|
|
8
|
Lang-Lazdunski L, Bille A, Lal R, Cane P,
McLean E, Landau D, Steele J and Spicer J:
Pleurectomy/decortication is superior to extrapleural pneumonectomy
in the multimodality management of patients with malignant pleural
mesothelioma. J Thorac Oncol. 7:737–743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shaikh F, Zauderer MG, von Reibnitz D, Wu
AJ, Yorke ED, Foster A, Shi W, Zhang Z, Adusumilli PS, Rosenzweig
KE, et al: Improved outcomes with modern lung-sparing trimodality
therapy in patients with malignant pleural mesothelioma. J Thorac
Oncol. 12:993–1000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Scherpereel A, Astoul P, Baas P, Berghmans
T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin
C, Hillerdal G, et al: Guidelines of the european respiratory
society and the european society of thoracic surgeons for the
management of malignant pleural mesothelioma. Eur Respir J.
35:479–495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gupta V, Mychalczak B, Krug L, Flores R,
Bains M, Rusch VW and Rosenzweig KE: Hemithoracic radiation therapy
after pleurectomy/decortication for malignant pleural mesothelioma.
Int J Radiat Oncol Biol Phys. 63:1045–1052. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rosenzweig KE, Zauderer MG, Laser B, Krug
LM, Yorke E, Sima CS, Rimner A, Flores R and Rusch V: Pleural
intensity-modulated radiotherapy for malignant pleural
mesothelioma. Int J Radiat Oncol Biol Phys. 83:1278–1283. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Minatel E, Trovo M, Bearz A, Di Maso M,
Baresic T, Drigo A, Barresi L, Furlan C, Del Conte A, Bruschi G, et
al: Radical radiation therapy after lung sparing surgery for
malignant pleural mesothelioma: Survival, pattern of failure and
prognostic factors. Int J Radiation Oncol Biol Phys. 93:606–613.
2015. View Article : Google Scholar
|
|
14
|
Hall EJ and Giaccia AJ: Radiobiology for
the radiologist. 7th ed. Lippincott Williams & Wilkins;
Philadelphia: 2011
|
